Success Metrics

Clinical Success Rate
93.8%

Based on 45 completed trials

Completion Rate
94%(45/48)
Active Trials
2(4%)
Results Posted
62%(28 trials)
Terminated
3(6%)

Phase Distribution

Ph phase_3
12
24%
Ph phase_1
3
6%
Ph phase_2
5
10%
Ph early_phase_1
1
2%
Ph not_applicable
9
18%
Ph phase_4
18
36%

Phase Distribution

4

Early Stage

5

Mid Stage

30

Late Stage

Phase Distribution48 total trials
Early Phase 1First-in-human
1(2.1%)
Phase 1Safety & dosage
3(6.3%)
Phase 2Efficacy & side effects
5(10.4%)
Phase 3Large-scale testing
12(25.0%)
Phase 4Post-market surveillance
18(37.5%)
N/ANon-phased studies
9(18.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.8%

45 of 48 finished

Non-Completion Rate

6.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

50

all time

Status Distribution
Active(2)
Completed(45)
Terminated(3)

Detailed Status

Completed45
Terminated3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
50
Active
2
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.1%)
Phase 13 (6.3%)
Phase 25 (10.4%)
Phase 312 (25.0%)
Phase 418 (37.5%)
N/A9 (18.8%)

Trials by Status

recruiting24%
terminated36%
completed4590%

Recent Activity

2 active trials
Showing 5 of 50
recruitingphase_3

Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea

NCT07332442
completedphase_3

National Adaptive Trial for PTSD Related Insomnia

NCT03668041
completedphase_4

Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD

NCT03937713
recruitingphase_2

Do Endotypes Predict Response and Sequelae in OSA Patients

NCT04875364
completedphase_2

Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea

NCT04639193
View all 50 trials

Clinical Trials (50)

Showing 20 of 50 trialsScroll for more
NCT07332442Phase 3

Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea

Recruiting
NCT03668041Phase 3

National Adaptive Trial for PTSD Related Insomnia

Completed
NCT03937713Phase 4

Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD

Completed
NCT04875364Phase 2

Do Endotypes Predict Response and Sequelae in OSA Patients

Recruiting
NCT04639193Phase 2

Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea

Completed
NCT02456532Phase 4

Safety and Efficacy of Chronic Hypnotic Use 2

Completed
NCT00812214Phase 4

Treatment of Insomnia in Migraineurs

Completed
NCT01605253Phase 4

Eszopiclone for the Treatment of Posttraumatic Stress Disorder

Completed
NCT00511134Phase 4

Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban

Terminated
NCT00392041Phase 4

Eszopiclone in the Treatment of Insomnia and Fibromyalgia

Completed
NCT02087488Not Applicable

Auricular Acupuncture for Primary Insomnia

Completed
NCT01887691Phase 1

Sleep Effectiveness and Insulin and Glucose Homeostasis

Terminated
NCT00374556Not Applicable

Insomnia and Osteoarthritis Study

Completed
NCT02455271

Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients

Completed
NCT02452684

Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients

Completed
NCT00247624Phase 4

Improving Sleep and Psychological Functioning in People With Depression and Insomnia

Completed
NCT00857220Phase 3

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Completed
NCT00889200Phase 4

Eszopiclone Treatment & Cortisol Responsivity

Completed
NCT00900159Not Applicable

Effects of Daytime Eszopiclone Administration in Shift Workers

Completed
NCT01641900Not Applicable

Effects of Eszopiclone on Sleep and Memory in Schizophrenia

Completed

Drug Details

Intervention Type
DRUG
Total Trials
50